Related Experiment Video

Updated: Aug 24, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.7K

The Comprehensive Analysis of Hub Gene ARRB2 in Prostate Cancer

Bing Zhou1, Hong Song1, Wuqin Xu1

  • 1Department of Pathology, Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui 241001, China.

Disease Markers
|October 26, 2022
PubMed
Abstract

Insights

The study identified ARRB2 as a key gene in prostate cancer (PRAD). High ARRB2 expression correlates with poor prognosis and promotes tumor growth, suggesting it as a potential target for PRAD immunotherapy.

Area of Science:

  • Oncology
  • Genomics
  • Immunotherapy

Background:

  • Prostate cancer (PRAD) research seeks novel therapeutic targets.
  • Understanding gene expression profiles is crucial for identifying PRAD biomarkers.

Purpose of the Study:

  • To identify a hub gene in PRAD using gene expression data.
  • To analyze the relationship between the hub gene, PRAD prognosis, and immunotherapy response.
  • To investigate the functional role of the hub gene in PRAD progression.

Main Methods:

  • Differential gene expression analysis of the GSE30994 dataset for PRAD.
  • Protein-protein interaction (PPI) network analysis to identify hub genes.
  • Correlation analysis with pan-cancer data, PRAD prognosis, and immune cells.
  • Functional experiments assessing effects on cell growth, metastasis, and inflammatory factors.

Main Results:

  • ARRB2 was identified as the hub gene, highly expressed in PRAD and associated with poor prognosis.
  • ARRB2 expression correlated with immune cell infiltration, including B cells, NK cells, and tumor-infiltrating lymphocytes (TILs).
  • Functional experiments confirmed ARRB2 promotes PRAD cell growth and metastasis and is linked to inflammatory factors.

Conclusions:

  • ARRB2 demonstrates significant prognostic value in PRAD.
  • ARRB2 represents a potential therapeutic target for PRAD immunotherapy.
  • This study provides new avenues for PRAD research and treatment strategies.

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.6K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K